ARGENTUM

01

Balancing the Rights of Pharmaceutical Innovators & Consumers

Argentum is an evolutionary generic drug company.

01

WHO WE ARE

02

PATENT  LITIGATION

03

PRODUCT TO MARKET

04

CASE  VICTORIES

05

LOWER COST GENERICS

ARGENTUM

02

We deploy proprietary A.I. and vast pharma patent litigation experience to identify and act against flawed pharmaceutical patents.

01

WHO WE ARE

02

PATENT  LITIGATION

03

PRODUCT TO MARKET

04

CASE  VICTORIES

05

LOWER COST GENERICS

ARGENTUM

03

We bring products to the market through our manufacturing partners & sales and distribution partnerships.

01

WHO WE ARE

02

PATENT  LITIGATION

03

PRODUCT TO MARKET

04

CASE  VICTORIES

05

LOWER COST GENERICS

ARGENTUM

04

We’ve led the charge on the ultimate invalidation of several multi-billion-dollar branded drug franchises

This includes the remaining final patents protecting Gilenya (fingolimod) and Zytiga (abiraterone acetate).

01

WHO WE ARE

02

PATENT  LITIGATION

03

PRODUCT TO MARKET

04

CASE  VICTORIES

05

LOWER COST GENERICS

ARGENTUM

05

We are a party to multiple settlements with branded drug companies

We negotiated in the interest of bringing lower-cost generic drugs to the market sooner than they would otherwise be brought to market.

01

WHO WE ARE

02

PATENT  LITIGATION

03

PRODUCT TO MARKET

04

CASE  VICTORIES

05

LOWER COST GENERICS

Argentum Pharmaceuticals LLC

301 East Hopkins Avenue,
Suite 201
Aspen, CO 81611